J 2020

Association of ionizing radiation dose from common medical diagnostic procedures and lymphoma risk in the Epilymph case-control study

PASQUAL, Elisa, Michelle C. TURNER, Esther GRACIA-LAVEDAN, Delphine CASABONNE, Yolanda BENAVENTE et. al.

Základní údaje

Originální název

Association of ionizing radiation dose from common medical diagnostic procedures and lymphoma risk in the Epilymph case-control study

Autoři

PASQUAL, Elisa (garant), Michelle C. TURNER, Esther GRACIA-LAVEDAN, Delphine CASABONNE, Yolanda BENAVENTE, Isabelle Thierry CHEF, Marc MAYNADIE, Pierluigi COCCO, Anthony STAINER, Lenka FORETOVÁ (203 Česká republika, domácí), Alexandra NIETERS, Paolo BOFFETTS, Paul BRENNAN, Elisabeth CARDIS a Silvia DE SANJOSE

Vydání

Plos one, San Francisco, Public Library of Science, 2020, 1932-6203

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30204 Oncology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 3.240

Kód RIV

RIV/00216224:14110/20:00124646

Organizační jednotka

Lékařská fakulta

UT WoS

000552603900025

Klíčová slova anglicky

lymphoma; ionizing radiation dose

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 20. 5. 2022 10:46, Mgr. Tereza Miškechová

Anotace

V originále

Medical diagnostic X-rays are an important source of ionizing radiation (IR) exposure in the general population; however, it is unclear if the resulting low patient doses increase lymphoma risk. We examined the association between lifetime medical diagnostic X-ray dose and lymphoma risk, taking into account potential confounding factors, including medical history. The international Epilymph study (conducted in the Czech-Republic, France, Germany, Ireland, Italy, and Spain) collected self-reported information on common diagnostic X-ray procedures from 2,362 lymphoma cases and 2,465 frequency-matched (age, sex, country) controls. Individual lifetime cumulative bone marrow (BM) dose was estimated using time period-based dose estimates for different procedures and body parts. The association between categories of BM dose and lymphoma risk was examined using unconditional logistic regression models adjusting for matching factors, socioeconomic variables, and the presence of underlying medical conditions (atopic, autoimmune, infectious diseases, osteoarthritis, having had a sick childhood, and family history of lymphoma) as potential confounders of the association. Cumulative BM dose was low (median 2.25 mGy) and was not positively associated with lymphoma risk. Odds ratios (ORs) were consistently less than 1.0 in all dose categories compared to the reference category (less than 1 mGy). Results were similar after adjustment for potential confounding factors, when using different exposure scenarios, and in analyses by lymphoma subtype and by type of control (hospital-, population-based). Overall no increased risk of lymphoma was observed. The reduced ORs may be related to unmeasured confounding or other sources of systematic bias.We found little evidence that chronic medical conditions confound lymphoma risk and medical radiation associations.